Patent classifications
B01D15/1821
METHODS FOR THE PURIFICATION OF L-GLUFOSINATE
Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate. In some embodiments, a portion of the glutamate in the starting composition may be separated from the L-glufosinate using a crystallization step. Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are also described.
Chromatography system and method
A chromatography system comprising at least two chromatography columns, where a feed recirculation of outflow from a primary load column to the inlet of a secondary load column is combined such that the feed recirculation outflow from all columns that will be used as primary load columns in the system will pass through one and the same feed recirculation flow path.
Method for inline measurement on simulated moving bed units or hybrid units for separation by simulated moving bed and crystallization, and application to the control and regulation of said units
A method for measuring the concentrations of species present at at least one point of a separation unit operating in simulated moving bed (SMB) mode, or a hybrid separation unit employing a step for simulated moving bed (SMB) separation and a step for crystallization, by calibration by inline acquisition of Raman spectra for different mixtures; analysis by inline signal processing of the Raman spectrum.
PROCESS FOR PURIFICATION AND SEPARATION OF CANNABINOIDS, FROM DRIED HEMP AND CANNABIS LEAVES
Disclosed is a method for purification and separation of cannabinoids, specifically cannabidiol and tetrahydrocannabinol, from the dried hemp and cannabis leaves using a combination of a sequence of purification steps including: filtration, decolorization, activation or decarboxylation, dewaxing, a continuous simulated moving bed process, polishing, and crystallization to separate cannabinoids from tetrahydrocannabinol and to provide phytocannabinoid rich oil and cannabidiol isolate. The cannabinoid products can be used in various pharmaceutical and nutraceutical applications.
PROCESS FOR PURIFICATION AND SEPARATION OF CANNABINOIDS, FROM DRIED HEMP AND CANNABIS LEAVES
A method for purification and separation of cannabinoids, such as cannabidiol and tetrahydrocannabinol, e.g., from the dried hemp and cannabis leaves can use a continuous simulated moving bed process and a combination of one or more of a sequence of purification steps including: filtration, decolorization, activation or decarboxylation, dewaxing, polishing, and crystallization to separate a cannabinoid from the cannabis plant and to provide various cannabinoid products. The cannabinoid products can be used in various pharmaceutical and nutraceutical applications.
PROCESS FOR SEPARATING A CONSTITUENT/CANNABINOID USING A CHROMATOGRAPHIC RESIN
A method for purification and separation of cannabinoids, such as cannabidiol and tetrahydrocannabinol, e.g., from dried hemp and cannabis leaves can use a continuous simulated moving bed process, a batch column chromatography method, or a single column, and a combination of one or more of a sequence of purification steps including: filtration, decolorization, activation or decarboxylation, dewaxing, polishing, and crystallization to separate a cannabinoid from the cannabis plant and to provide various cannabinoid products. The cannabinoid products can be used in various pharmaceutical and nutraceutical applications.
Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.
METHOD FOR SIMULATED MOVING BED TO ADSORB AND SEPARATE POLYCYCLIC AROMATIC HYDROCARBONS
The present disclosure relates to a method for a simulated moving bed to adsorb and separate polycyclic aromatic hydrocarbons. Zeolite, metal oxide and metal-modified materials are employed as adsorbent. Firstly, diesel oil flows through pre-treatment adsorbent to remove the trace amount of impurities. Secondly, the purified diesel oil flows through the simulated moving bed so that the PAHs can be separated from diesel oil. In this process, the valves are switched periodically, leading to the relative movement of adsorption beds. At the same time, desorbent is pumped into the equipment to wash out PAHs, achieving the continuous adsorption-regeneration operation. Thirdly, simple distillation is employed to separate desorbent from clean diesel oil and PAHs, respectively. Finally, the fractions of clean diesel oil and PAHs can be obtained, respectively. The separated desorbent can be recycled. The PAHs removal rate can reach to 90%.
METHODS FOR THE PURIFICATION OF L-GLUFOSINATE
Compositions and methods for isolating L-glufosinate from a composition comprising L-glufosinate and glutamate are provided. The method comprises converting the glutamate to pyroglutamate followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The composition comprising L-glufosinate and glutamate is subjected to an elevated temperature for a sufficient time to allow for the conversion of glutamate to pyroglutamate, followed by the isolation of L-glufosinate from the pyroglutamate and other components of the composition to obtain substantially purified L-glufosinate. The glutamate alternatively may be converted to pyroglutamate by enzymatic conversion. The purified L-glufosinate is present in a final composition at a concentration of 90% or greater of the sum of L-glufosinate, glutamate, and pyroglutamate. In some embodiments, a portion of the glutamate in the starting composition may be separated from the L-glufosinate using a crystallization step. Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium, are also described.
A PROCESS FOR PURIFICATION OF POLYETHER BLOCK COPOLYMERS
A process for purification of polyether block copolymers comprising polyoxyethylene and polyoxypropylene moieties using sequential multi-column size exclusion chromatography apparatus operated as a counter current moving bed wherein a process cycle comprises the steps of.